hydrazine has been researched along with Basal Ganglia Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gerlach, J; Lühdorf, K | 1 |
Miller, EM; Wiener, L | 1 |
1 trial(s) available for hydrazine and Basal Ganglia Diseases
Article | Year |
---|---|
The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo.
Topics: Adult; Affect; Antipsychotic Agents; Anxiety; Basal Ganglia Diseases; Benserazide; Brief Psychiatric Rating Scale; Clinical Trials as Topic; Drug Combinations; Emotions; Humans; Hydrazines; Levodopa; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Social Behavior | 1975 |
1 other study(ies) available for hydrazine and Basal Ganglia Diseases
Article | Year |
---|---|
Ro 4-4602 and levodopa in the treatment of Parkinsonism.
Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Basal Ganglia Diseases; Carbidopa; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Gastrointestinal Diseases; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease | 1974 |